Manufacturer record
Bajaj Formulations: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Bajaj Formulations (Uttarakhand) were declared Not of Standard Quality between December 2021 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
10 records linked to Bajaj Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac and Parcetamol IP) | T251733CMfg 2025-09 · Exp 2027-08 | 01. ASSAY OF ACECLOFENAC I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Diabit-GM | T25F640AMfg 2025-06 · Exp 2027-05 | The sample fails in the Test for DescriptionDescription | MDTL KathuaState lab | Apr 2026 |
| Metformin Hydrochloride (SR) & Glimepride Tablets IP (Yathoglim-M3) | T25C554AMfg 2025-03 · Exp 2027-02 | Sample fail the test Assay of Glimepiride.Assay | RDTL, Ernakulam, KeralaState lab | Oct 2025 |
| Intraconazole Capsules 100 mg (ITRASEC-100) | C24I028DMfg 2024-09 · Exp 2026-08 | The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.Dissolution | CDL, KolkataCDSCO lab | Oct 2025 |
| Pantoprazole 40mg | T24E999AMfg 2024-05 · Exp 2026-04 | DissolutionDissolution | DTL,Dalgate Srinagar Kashmir(J&K)State lab | Aug 2025 |
| Kresertan - 40 | T24E178AMfg 2024-05 · Exp 2026-04 | Failing in Disintegration Test.Disintegration | Drug Testing Laboratory Dalgate, SrinagarState lab | Jul 2025 |
| Racecadotril & Oflozacin Suspension (Combact-O + Suspension) | L23J003AMfg 2023-10 · Exp 2025-09 | Assay of Racecadotril & OfloxacinAssay | CDTL MumbaiCDSCO lab | Oct 2024 |
| Levocetrizine Dihydrochloride & Montelukast Sodium Tablets I.P. Zeemont | T22H370CMfg 2022-08 · Exp 2024-07 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR MONTELUKAST.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Levetiracetam Tablets U.S.P.500 Mg (LEVEEG-500) | T23D050AMfg 2023-04 · Exp 2025-03 | THE SAMPLE DOES NOT COMPLY WITH USP REQUIREMENTS FOR DISSOLUTION.Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Acebrophylline (SR), Fexofenadine Hydrochloride and Montelukast Sodium Tablets (LEVOICE-3D TABLETS) | T21G522DMfg 2021-07 · Exp 2023-06 | Assay of Montelukast Sodium calculated as MontelukastAssay | RDTL ChandigarhState lab | Dec 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.